Mesenchymal stem cells in inflammatory microenvironment potently promote metastatic growth of cholangiocarcinoma <i>via</i> activating Akt/NF-κB signaling by paracrine CCL5

Wei Zhong, Yinping Tong, Yang Li, J. Yuan, Shaoping Hu, Tianhui Hu, Gang Song

Oncotarget · 2017 · 56 citations · 23 references

DOIFull text

Open access

Concepts

Abstract

// Wei Zhong 1, 2 , Yinping Tong 1 , Yang Li 1 , Jiahui Yuan 1 , Shaoping Hu 1 , Tianhui Hu 1 and Gang Song 1 1 Cancer Research Center, Medical College of Xiamen University, Xiamen 361102, China 2 Department of General Surgery, The Affiliated Southeast Hospital of Xiamen University, Zhangzhou 363000, China Correspondence to: Gang Song, email: gangsongsd@xmu.edu.cn Keywords: cholangiocarcinoma, mesenchymal stem cell, inflammatory microenvironment, CCL5 Received: June 15, 2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accepted: April 18, 2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Published: May 11, 2017 ABSTRACT Our previous work has demonstrated that mesenchymal stem cells (MSCs) could induce metastatic growth of the inflammation-related cholangiocarcinoma (CCA). However, the functional mechanism of MSCs on CCA progression in the early inflammatory microenvironment remained undetermined. Here, we showed that TNF-&alpha; and IFN-&gamma;-induced inflammatory microenvironment stimulated the expression of TNF-&alpha;, CCL5, IL-6, IDO, and activated the NF-&kappa;B signaling with p65 nuclear translocation in MSCs cells. CCA cell lines QBC939 and Mz-chA-1 exposed to the conditioned medium of MSCs after being stimulated by TNF-&alpha; and IFN-&gamma; (TI-CM) exhibited enhanced mobility. Moreover, MSCs pre-stimulated by both inflammatory cytokines (TI-MSCs) increased tumor metastasis in vivo . The conditioned medium of TI-MSCs stimulated the transcription of snail , slug , ZEB1 and ZEB2 . Next, the expression of CCL5 of TI-MSCs was verified by ELISA, which indicated that MSCs contributed to CCA migration and metastasis in a paracrine fashion. CCA cells treated with TI-CM up-regulated CCA chemokine receptors, especially CCR5; CCL5 neutralizing antibody or CCR5 inhibitor Maraviroc inhibited the effects of MSCs on CCA cells migration. We also found that Akt/NF-&kappa;B signaling was activated by CCL5/CCR5 axis, which increased the expression of MMP2, MMP9. Together, these findings suggest that MSCs in tumor inflammatory microenvironment are elicited of CCL5, which activate AKT/NF-&kappa;B signaling and lead to metastatic growth of CCA cells.

References

23